Economic TimesLean R·
Action on against high-risk pharma cos
NEW DELHI: India has taken enforcement action against about 90% of inspected pharmaceutical facilities identified as high-risk under a nationwide quality drive, the drug regulator's chief said, as authorities step up oversight following global scrutiny of Indian-made drugs.The crackdown is part of a broader effort to strengthen quality standards in India, often called the "pharmacy of the world", after Indian-made cough syrups were linked by global health authorities to child deaths in co…
Read at Economic Times →
